Related references
Note: Only part of the references are listed.Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
Junfei Hu et al.
JOURNAL OF HEPATOLOGY (2016)
Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
Zheng Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Are There Genetic Paths Common to Obesity, Cardiovascular Disease Outcomes, and Cardiovascular Risk Factors?
Tuomo Rankinen et al.
CIRCULATION RESEARCH (2015)
Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Positive Regulator of Pathological Cardiac Hypertrophy
Xi Jiang et al.
HYPERTENSION (2015)
Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke
Jun Gong et al.
HYPERTENSION (2015)
Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury
Pi-Xiao Wang et al.
JOURNAL OF HEPATOLOGY (2015)
Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance
Xin-An Wang et al.
HEPATOLOGY (2014)
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Sayaka Inokuchi-Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
Li-Hua Zhu et al.
JOURNAL OF HEPATOLOGY (2014)
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Rachel J. Perry et al.
NATURE (2014)
Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling
Wei Liu et al.
NATURE COMMUNICATIONS (2014)
HSCARG Negatively Regulates the Cellular Antiviral RIG-I Like Receptor Signaling Pathway by Inhibiting TRAF3 Ubiquitination via Recruiting OTUB1
Yanyan Peng et al.
PLOS PATHOGENS (2014)
RNF26 Temporally Regulates Virus-Triggered Type I Interferon Induction by Two Distinct Mechanisms
Yue Qin et al.
PLOS PATHOGENS (2014)
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
Xin-An Wang et al.
HEPATOLOGY (2013)
Differential Roles of ASK1 and TAK1 in Helicobacter pylori-Induced Cellular Responses
Yoku Hayakawa et al.
INFECTION AND IMMUNITY (2013)
PATHOPHYSIOLOGY OF HUMAN VISCERAL OBESITY: AN UPDATE
Andre Tchernof et al.
PHYSIOLOGICAL REVIEWS (2013)
Cell type-specific function of TAK1 in innate immune signaling
Adebusola A. Ajibade et al.
TRENDS IN IMMUNOLOGY (2013)
Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer
Kostas Nikolaou et al.
CANCER CELL (2012)
The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Robert V. Farese et al.
CELL METABOLISM (2012)
Autophagy in regulation of Toll-like receptor signaling
Takeshi Into et al.
CELLULAR SIGNALLING (2012)
Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses
Zheng Chen et al.
DIABETES (2012)
Deficiency of Carboxylesterase 1/Esterase-x Results in Obesity, Hepatic Steatosis, and Hyperlipidemia
Ariel D. Quiroga et al.
HEPATOLOGY (2012)
NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
Liang Sheng et al.
NATURE MEDICINE (2012)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
TAK1 Lys-158 but not Lys-209 is required for IL-1β-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation
Yihui Fan et al.
CELLULAR SIGNALLING (2011)
Insulin signaling to hepatic lipid metabolism in health and disease
Karla F. Leavens et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Non-alcoholic fatty liver disease
Briohny W. Smith et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Expanding TRAF function: TRAF3 as a tri-faced immune regulator
Hans Haecker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Human TRAF3 Adaptor Molecule Deficiency Leads to Impaired Toll-like Receptor 3 Response and Susceptibility to Herpes Simplex Encephalitis
Rebeca Perez de Diego et al.
IMMUNITY (2010)
The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways
Dan Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autoactivation of Transforming Growth Factor β-activated Kinase 1 Is a Sequential Bimolecular Process
Roland Scholz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TRAF3 Controls Activation of the Canonical and Alternative NFκB by the Lymphotoxin Beta Receptor
Pradeep Bista et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines
Ping-Hui Tseng et al.
NATURE IMMUNOLOGY (2010)
Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes
Michael Karin et al.
IMMUNOLOGICAL REVIEWS (2009)
Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex
Atsushi Matsuzawa et al.
SCIENCE (2008)
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Herbert Tilg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
DUBA: A deubiquitinase that regulates type I interferon production
Nobuhiko Kayagaki et al.
SCIENCE (2007)
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
Isabelle A. Leclercq et al.
JOURNAL OF HEPATOLOGY (2007)
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver
Michihiro Matsumoto et al.
CELL METABOLISM (2007)
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
Gurol Tuncman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TRAF3: a new component of the TLR-signaling apparatus
Kasper Hoebe et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease
J Poniachik et al.
CYTOKINE (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction
DJ Adams et al.
GENOMICS (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responses
S Sato et al.
NATURE IMMUNOLOGY (2005)
Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2
P Singhirunnusorn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis
LG Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors
N Lazarevich et al.
HEPATOLOGY (2004)
Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40
AG Eliopoulos et al.
EMBO JOURNAL (2003)
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade
YH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
Tumor necrosis factor receptor-associated factors (TRAFs)
JR Bradley et al.
ONCOGENE (2001)
TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase
A Hatzoglou et al.
JOURNAL OF IMMUNOLOGY (2000)
The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307
V Aguirre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
